Effect of verapamil on regional coronary and myocardial perfusion during acute coronary occlusion.
D000208:Acute Disease; D000818:Animals; D001157:Arterial Occlusive Diseases / Q000503:physiopathology*; D001794:Blood Pressure / Q000187:drug effects; D003326:Coronary Circulation / Q000187:drug effects*; D003327:Coronary Disease / Q000503:physiopathology; D003331:Coronary Vessels / Q000503:physiopathology*; D004285:Dogs; D004562:Electrocardiography; D005260:Female; D006321:Heart / Q000187:drug effects*; D006339:Heart Rate / Q000187:drug effects; D006439:Hemodynamics / Q000187:drug effects; D008297:Male; D010101:Oxygen Consumption / Q000187:drug effects; D010477:Perfusion; D014700:Verapamil / Q000494:pharmacology*
D014700:Verapamil